Global Archives – Page 25 of 25 – Treatment Action Group

First-Ever Targeted Roadmap Outlines Steps to End Childhood TB Deaths

October 1, 2013
Chad Cipiti

Cost to end deaths from childhood TB estimated to be at least US$120 million annually WASHINGTON D.C. | October 1, 2013 -- The deaths of more than 74 000 children from tuberculosis (TB) could be prevented each year through measures outlined…

Treatment Action Group and the Stop TB Partnership Issue Update on 2011 Global TB R&D Investment Trends

November 14, 2012
Chad Cipiti

For the seventh year, Treatment Action Group (TAG) and the Stop TB Partnership have published the latest investment data on the state of global tuberculosis (TB) research and development (R&D) funding.

Letter to the EMA: Conducting drug-drug interaction studies for bedaquiline (TMC207) and delamanid (OPC6783)

May 24, 2012
Chad Cipiti

May 24, 2012 TO: Marco Cavaleri CC: Hans-Georg Eichler European Medicines Agency 7 Westferry Circus- Canary Whar London E14 4 HB United Kingdom RE: Conducting drug-drug interaction studies for bedaquiline (TMC207) and delamanid (OPC6783) Dear Dr. Cavaleri, We wish to draw…

Strengthening the Role of the Stop TB Partnership in the Struggle Against Tuberculosis

October 14, 2011
Chad Cipiti

A follow up to the letter of May 3, 2011, regarding the steps being taken by the Coordinating Board to reduce the conflict of interest in the Stop TB Partnership’s relationship with the World Health Organization (WHO), improve transparency and accountability in the operations and activities of the Partnership, and strengthen the Partnership’s ability to fulfill its mandate.